In mice expressing the thanatophoric dysplasia type II activating FGFR3 mutation, the defect in chondrocyte maturation and bone formation was linked to increased SOX9 protein stability (51, 52). The gene discussed is SOX9; the disease is thanatophoric dysplasia type 2.